Pharsight Corporation has signed a deal with InforSense under which InforSense will distribute Pharsight’s early stage clinical development management software in China. InforSense will be responsible for marketing and distribution, as well as end-user training, maintenance and support services. InforSense is based in London, though it has established a Shanghai office. Pharsight's software provides pharmacokinetic and pharmacodynamic (PK/PD) analysis and trial simulation, including support for reporting, archiving, and data visualization. More details...

Stock Symbol: (NSDQ: PHST)